| NCT ID | NCT04650607 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Prosthetic Joint Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-05-09 |
| Primary Completion | 2023-10-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-05-09 with a primary completion date of 2023-10-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This cohort study aims to describe the adverse events related to the use of bacteriophages to treat serious infections, data from the literature being almost non-existent on this subject.
Eligibility Criteria
Inclusion Criteria: * Patient 18 years of age or older with a serious infection treated at CRIOAc Lyon by phage therapy * Patient who did not object to participating in the study * Patients ayant un poids minimum de 46kg Exclusion Criteria: * Patients under guardianship/curatorship * Patients deprived of liberty * Pregnant or breastfeeding women
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04650607 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Prosthetic Joint Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04650607 currently recruiting?
Yes, NCT04650607 is actively recruiting participants. Contact the research team at johanna.boulant@chu-lyon.fr for enrollment information.
Where is the NCT04650607 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT04650607 clinical trial?
NCT04650607 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 100 participants.